PAYP vs RMBS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PAYP presents a dichotomy between strong operational performance and concerning financial health. While the Piotroski F-Score of 4/9 indicates stable but mediocre health, the company boasts impressive profit margins (31.28%) and robust YoY earnings growth (27.30%). However, liquidity is a primary concern with a current ratio of 0.94 and a high debt-to-equity ratio of 1.81. The stock trades significantly above its Graham Number ($8.14) but below its growth-based intrinsic value ($30.98), suggesting a premium based on growth expectations that is currently fighting a bearish technical trend.
RMBS exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet (Debt/Equity 0.02). However, the stock is severely overvalued, trading at $126.93—over 5x its Graham Number of $24.52 and 6x its growth-based intrinsic value of $19.83. While profitability margins are elite (80.56% gross margin), the divergence between strong revenue growth (18.1%) and stagnant earnings growth (1.6%) suggests diminishing returns. Combined with bearish insider selling and a weak technical trend, the current price appears unsustainable.
Compare Another Pair
Related Comparisons
PAYP vs RMBS: Head-to-Head Comparison
This page compares PayPay Corporation (PAYP) and Rambus Inc. (RMBS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.